This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 602053
Submitted by lobbyist on: December 5, 2016 09:13:19 AM
Accepted by Registrar on: December 5, 2016 09:46:14 AM
Designated Filer Information
| McCarthy, Daniel |
| 2600 Alfred Nobel Boulevard Suite 400 | |
|
Ville Saint Laurent, QC, H4S 0A9
|
514-940-7711 |
| Canada |
Organization Information
| Lundbeck Canada Inc. |
| Lundbeck Canada develops, manufactures and/or sells innovative biopharmaceutical products for the treatment of disorders originating in the central nervous system and for the treatment of cancer. |
| 2600 Alfred Nobel Boulevard Suite 400 | |
|
Ville Saint-Laurent, QC, H4S 0A9
|
514-940-9982 |
| Canada |
Relevant Affiliates
Type:
| Business Name | Mailing Address | Contact Information |
|---|---|---|
| H. Lundbeck A/S |
9 Ottilavej
Copenhagen, Valby DK-2500, Denmark |
Phone: 5149407711 |
Government or Government Agency Funding
Other Controlling or Directing Interests
Active Registration Period
| December 5, 2016 | |
| June 3, 2017 |
Organization's In-House Lobbyists
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
To introduce the Lundbeck organization and its product portfolio and services to the Ministry of Health and known public cancer agencies in British Columbia. Attempt to influence BC PharmaCare and the BCCA reimbursement policies and policy in general at a ministerial level.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Lake, Terry | Minister of Health | December 5, 2016 |
| Public Agency | Health | December 5, 2016 | |
| Public Agency | Provincial Health Services Authority | December 5, 2016 |
Health
Development, establishment, amendment or termination of any program, policy or decision
Meet, discuss and negotiate with staff within the Pharmaceutical Services Division, Health Services Authority and/or Cancer Agencies, as appropriate, with respect to access and reimbursement listing decisions for Lundbeck Canada's portfolio of medicines.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Lake, Terry | Minister of Health | December 5, 2016 |
| Public Agency | Health | December 5, 2016 | |
| Public Agency | Provincial Health Services Authority | December 5, 2016 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
To introduce the Lundbeck organization and its product portfolio and services to the Ministry of Health and known public cancer agencies in British Columbia. Attempt to influence BC PharmaCare and the BCCA reimbursement policies and policy in general at a ministerial level.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Lake, Terry | Minister of Health | December 5, 2016 |
| Public Agency | Health | December 5, 2016 | |
| Public Agency | Provincial Health Services Authority | December 5, 2016 |
Health
Development, establishment, amendment or termination of any program, policy or decision
Meet, discuss and negotiate with staff within the Pharmaceutical Services Division, Health Services Authority and/or Cancer Agencies, as appropriate, with respect to access and reimbursement listing decisions for Lundbeck Canada's portfolio of medicines.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Lake, Terry | Minister of Health | December 5, 2016 |
| Public Agency | Health | December 5, 2016 | |
| Public Agency | Provincial Health Services Authority | December 5, 2016 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
To introduce the Lundbeck organization and its product portfolio and services to the Ministry of Health and known public cancer agencies in British Columbia. Attempt to influence BC PharmaCare and the BCCA reimbursement policies and policy in general at a ministerial level.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Lake, Terry | Minister of Health | December 5, 2016 |
| Public Agency | Health | December 5, 2016 | |
| Public Agency | Provincial Health Services Authority | December 5, 2016 |
Health
Development, establishment, amendment or termination of any program, policy or decision
Meet, discuss and negotiate with staff within the Pharmaceutical Services Division, Health Services Authority and/or Cancer Agencies, as appropriate, with respect to access and reimbursement listing decisions for Lundbeck Canada's portfolio of medicines.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Lake, Terry | Minister of Health | December 5, 2016 |
| Public Agency | Health | December 5, 2016 | |
| Public Agency | Provincial Health Services Authority | December 5, 2016 |